Boryung Pharm (003850) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Based on the latest financial reports, Boryung Pharm (003850) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩48.95 Billion ≈ $33.18 Million USD) by net assets (₩818.35 Billion ≈ $554.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Boryung Pharm to measure how many days the company can operate on defensive assets alone.

Boryung Pharm - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Boryung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Boryung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boryung Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TINC Comm VA BR:TINC	0.022x
SPAR Group Ltd JSE:SPP	0.553x
Ningbo Zhongbai Co Ltd SHG:600857	0.015x
ARTRYA Ltd AU:AYA	-0.122x
Jee Technology Co. Ltd. A SHG:688162	N/A
Mesa Laboratories Inc NASDAQ:MLAB	0.100x
Universal Health Realty Income Trust NYSE:UHT	0.081x
Martinrea International Inc. TO:MRE	-0.002x

Annual Cash Flow Conversion Efficiency for Boryung Pharm (2009–2024)

The table below shows the annual cash flow conversion efficiency of Boryung Pharm from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Boryung Pharm stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩784.50 Billion ≈ $531.65 Million	₩80.56 Billion ≈ $54.59 Million	0.103x	+33.57%
2023-12-31	₩549.25 Billion ≈ $372.22 Million	₩42.22 Billion ≈ $28.61 Million	0.077x	+42.73%
2022-12-31	₩516.42 Billion ≈ $349.97 Million	₩27.81 Billion ≈ $18.85 Million	0.054x	-57.54%
2021-12-31	₩474.31 Billion ≈ $321.44 Million	₩60.17 Billion ≈ $40.77 Million	0.127x	-3.52%
2020-12-31	₩340.29 Billion ≈ $230.61 Million	₩44.74 Billion ≈ $30.32 Million	0.131x	-20.84%
2019-12-31	₩282.95 Billion ≈ $191.75 Million	₩47.00 Billion ≈ $31.85 Million	0.166x	+9.32%
2018-12-31	₩256.10 Billion ≈ $173.56 Million	₩38.91 Billion ≈ $26.37 Million	0.152x	+254.12%
2017-12-31	₩249.65 Billion ≈ $169.19 Million	₩-24.61 Billion ≈ $-16.68 Million	-0.099x	-305.69%
2016-12-31	₩195.35 Billion ≈ $132.39 Million	₩9.36 Billion ≈ $6.35 Million	0.048x	-61.98%
2012-12-31	₩145.79 Billion ≈ $98.80 Million	₩18.38 Billion ≈ $12.46 Million	0.126x	+89.34%
2011-12-31	₩137.97 Billion ≈ $93.50 Million	₩9.19 Billion ≈ $6.23 Million	0.067x	-62.35%
2010-12-31	₩136.41 Billion ≈ $92.44 Million	₩24.12 Billion ≈ $16.35 Million	0.177x	+510.22%
2009-12-31	₩124.01 Billion ≈ $84.04 Million	₩3.59 Billion ≈ $2.44 Million	0.029x	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$525.57 Million

₩775.53 Billion KRW

Market Cap Rank

#12107 Global

#350 in Korea

Share Price

₩9180.00

Change (1 day)

-3.67%

52-Week Range

₩7920.00 - ₩10680.00

All Time High

₩21257.60